Reported mechanisms on CRC include the promotion of insulin resistance when adiponectin levels are low, leading to increased insulin growth factor-1 (IGF-1), which further promotes cellular proliferation, inhibits cell apoptosis, and upregulates VEGF (Figure 2). The gene discussed is ADIPOQ; the disease is colorectal carcinoma.